How to Get Orladeyo (Berotralstat) Covered by Blue Cross Blue Shield in Florida: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Orladeyo Covered by Florida Blue Cross Blue Shield

Orladeyo (berotralstat) requires prior authorization from Florida Blue Cross Blue Shield as a Tier 4 specialty drug with a $150 copay after deductible. To get coverage, you need: (1) confirmed HAE diagnosis with C1-INH testing, (2) documented attack frequency (≥2 severe attacks per month or equivalent), and (3) prior authorization submission through your prescriber via Florida Blue's portal. If denied, you have 180 days for internal appeal, then 4 months for external review through Florida DFS. Start by having your HAE specialist submit the PA request with complete lab work and attack history documentation.

First step today: Contact your prescribing physician to initiate the prior authorization process through Florida Blue's provider portal.

Table of Contents

Understanding Florida Blue's Coverage Requirements

Florida Blue classifies Orladeyo as a Tier 4 specialty medication that requires prior authorization and must be dispensed through designated specialty pharmacies. Here's what you need to know:

Coverage at a Glance

Requirement Details Where to Verify Source
Prior Authorization Required for all Orladeyo prescriptions Provider portal or member services Florida Blue PA Requirements
Formulary Tier Tier 4 specialty drug 2026 Medication Guide Florida Blue Formulary
Copay Structure $150 after $500 deductible Plan-specific benefits Member portal
Specialty Pharmacy Required dispensing channel Varies by plan (ValueScript, NetResults, etc.) Specialty Pharmacy Info
Age Requirement 12 years or older FDA labeling Orladeyo Prescribing Information
Step Therapy May apply - confirm with plan Plan documents Provider portal

Key Clinical Requirements

For Orladeyo coverage, Florida Blue requires documentation of:

  • Confirmed HAE diagnosis with appropriate laboratory testing (C1-INH levels, C4 complement)
  • Attack frequency demonstrating need for prophylaxis (typically ≥2 severe attacks per month)
  • Specialist involvement (allergist, immunologist, or HAE expert)
  • Prior therapy considerations if step therapy applies to your specific plan

Step-by-Step: Fastest Path to Approval

1. Confirm Your HAE Diagnosis

Who: Your HAE specialist or allergist
What: Complete diagnostic workup including C1-INH functional and antigenic levels, C4 complement
Timeline: Allow 1-2 weeks for lab results
Source: HAE Diagnostic Guidelines

2. Document Attack History

Who: You and your healthcare team
What: Detailed record of attack frequency, severity, anatomical locations, and impact on daily activities
Timeline: Ongoing documentation recommended

3. Submit Prior Authorization

Who: Your prescribing physician
What: Complete PA form through Florida Blue's provider portal with all supporting documentation
Timeline: Submit immediately after prescription written
Portal: Florida Blue Provider PA System

4. Track Your Request

Who: You or your clinic staff
What: Monitor PA status and respond to any requests for additional information
Timeline: Florida Blue typically responds within 72 hours to 30 days

5. Prepare for Potential Appeal

Who: Your healthcare team with your involvement
What: Gather comprehensive medical records, attack logs, and specialist letters
Timeline: Start preparation immediately if initial PA is denied

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
Insufficient attack frequency Provide detailed attack log showing ≥2 severe episodes per month Attack diary, emergency room visits, missed work/school days
Missing specialist involvement Get referral to HAE specialist Letter from allergist/immunologist confirming diagnosis
Incomplete diagnostic workup Submit all required lab results C1-INH functional/antigenic levels, C4 complement, genetic testing if applicable
Step therapy not completed Document trials/failures of other HAE prophylaxis Medical records showing inadequate response or intolerance to alternatives
Age restriction Confirm patient is ≥12 years old Birth certificate or medical records with date of birth
Tip: The most common reason for Orladeyo denials is incomplete attack documentation. Keep a detailed log including dates, severity, anatomical locations, and functional impact.

Appeals Playbook for Florida

Internal Appeal Process

Timeline: 180 days from denial notice
Submission: Through Florida Blue's Medical and Pharmacy Drug PA Portal via Availity or CoverMyMeds
Required Documents:

  • Original denial letter
  • Complete medical records
  • Laboratory results
  • Prior treatment documentation
  • Letter of medical necessity from prescriber

Contact: Florida Blue at 1-877-719-2583 for appeal requirements and forms

Peer-to-Peer Review Option

If your initial PA or appeal is denied, your prescribing physician can request a peer-to-peer review:

Phone: 1-877-719-2583
Scheduling: Within 1-3 business days of request
Preparation: Have medical file, FDA labeling, and necessity rationale ready

External Review Process

Eligibility: After exhausting internal appeals for medical necessity denials
Timeline: 4 months from final internal denial
Authority: Florida Department of Financial Services (DFS)
Contact: 1-877-693-5236 or online complaint system
Decision Timeline: 45 days standard, 72 hours for expedited urgent cases
Cost: Free to patients
Binding: Yes, on the insurer

Medical Necessity Letter Requirements

Clinician Corner: Essential Elements

Your prescribing physician's letter of medical necessity should include:

1. Patient Demographics & Diagnosis

  • Patient age (must be ≥12 years)
  • Confirmed HAE subtype with supporting lab values
  • ICD-10 codes (D84.1 for hereditary angioedema)

2. Clinical History

  • Detailed attack frequency and severity
  • Previous HAE treatments tried and outcomes
  • Contraindications to alternative therapies
  • Emergency interventions required

3. Treatment Rationale

  • Why Orladeyo is medically necessary for this patient
  • Expected therapeutic outcomes
  • Monitoring plan

4. Supporting Evidence

  • FDA labeling information
  • Relevant clinical guidelines
  • Peer-reviewed literature supporting use
Note: Include specific attack dates, locations (laryngeal, facial, abdominal), and functional impact. Vague statements like "frequent attacks" are insufficient.

Costs and Patient Assistance Options

Manufacturer Support Programs

BioCryst Patient Access Program

Additional Resources

Foundation Assistance

  • Patient Advocate Foundation: copay relief programs
  • National Organization for Rare Disorders (NORD): patient assistance programs
  • HealthWell Foundation: specialty drug assistance

Estimated Costs

  • WAC Price: $44,484.33 per 28-day supply (2025)
  • With Insurance: Varies by plan (typically $150 copay after deductible for Florida Blue)

When to Escalate to State Regulators

Contact the Florida Department of Financial Services if:

  • Florida Blue violates appeal timelines
  • You're not receiving required appeal rights
  • Procedural errors occur in the review process

Florida DFS Consumer Helpline: 1-877-693-5236
Email: [email protected]
Online: myfloridacfo.com

The DFS cannot force payment decisions but can ensure proper procedures are followed and document patterns of bad faith.

From Our Advocates

"We've seen the strongest Orladeyo approvals when patients work closely with HAE specialists who understand insurance requirements. One patient's approval was initially denied for 'insufficient documentation,' but succeeded on appeal when their allergist provided a comprehensive letter detailing specific attack patterns, emergency room visits, and why oral prophylaxis was preferred over injectable alternatives. The key was translating clinical need into insurance language."

FAQ: Most Common Questions

How long does Florida Blue prior authorization take?
Standard PA decisions are made within 30 days, but many are processed within 72 hours. Expedited reviews for urgent cases are completed within 72 hours.

What if Orladeyo isn't on my Florida Blue formulary?
You can request a formulary exception through the Coverage Exception Request process. Your physician will need to provide medical justification for why formulary alternatives aren't appropriate.

Can I get expedited approval if I'm having frequent attacks?
Yes, if your physician certifies that delays would jeopardize your health, you can request expedited review at both the PA and appeal levels.

Does step therapy apply to Orladeyo in Florida?
Step therapy requirements vary by specific Florida Blue plan. Check your plan documents or ask your physician to verify requirements during the PA submission.

What if I've tried HAE treatments in another state?
Documentation from out-of-state providers counts toward step therapy requirements. Ensure your current physician has complete records of prior treatments and outcomes.

How do I find a HAE specialist in Florida?
The Hereditary Angioedema Association maintains a provider directory of HAE specialists by state.


About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by creating targeted, evidence-backed rebuttals. The platform analyzes denial letters and plan policies to draft point-by-point appeals aligned with each insurer's specific requirements, pulling the right clinical evidence and procedural details to maximize approval chances.

For complex denials like Orladeyo coverage, having expert support can make the difference between prolonged delays and timely access to needed therapy. Counterforce Health's system is designed specifically to navigate the intricate requirements of specialty drug approvals and appeals.

Sources & Further Reading


This guide is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms and medical circumstances. Always consult with your healthcare provider and insurance plan for specific coverage questions. For additional help with insurance appeals in Florida, contact the Department of Financial Services Consumer Helpline at 1-877-693-5236.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.